Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?

被引：51

作者：

Schilsky M.L. ^{[1
]}

机构：

[1] Division of Liver Diseases, Department of Medicine, The Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1633, New York, 10029-6574, NY

来源：

Current Gastroenterology Reports | 2001年 / 3卷 / 1期

关键词：

Penicillamine; Pemphigus; Lichen Planus; Wilson Disease; Zinc Salt;

D O I：

10.1007/s11894-001-0041-4

中图分类号：

学科分类号：

摘要：

New options are available for the medical treatment of patients with Wilson's disease. Penicillamine is no longer the treatment of choice, as there is a growing experience with safer and more effective alternatives. Trientine may be the best choice for initial therapy in symptomatic patients requiring chelation therapy, and it may be even more effective when used in combination with zinc, which is recommended for maintenance therapy. Further studies are needed to determine the best therapy for pregnant patients with Wilson's disease, and whether combination therapy using trientine and zinc will be the next treatment of choice for all symptomatic patients with liver or neurologic disease.

引用

页码：54 / 59

页数：5

共 54 条

[1]

Schilsky ML(1994)Liver transplantation for Wilson’s disease: indications and outcome Hepatology 19 583-587

[2]

Scheinberg IH(1999)Liver transplantation for Wilson’s disease: a single-center experience Liver Transplant Surg 5 467-474

[3]

Sternlieb I(1998)ATP7B (WND) protein Int J Biochem Cell Biol 30 1063-1067

[4]

Eghtesad B(1999)Complete correction of liver disease following transplantation of normal hepatocytes in LEC rats that model Wilson’s disease [abstract] Hepatology 30 221A-221A

[5]

Nezakatgoo N(1995)Treatment of the neurologic manifestations of Wilson’s disease Arch Neurol 52 339-340

[6]

Geraci LC(1995)Commentary on Scheinberg and Sternlieb Arch Neurol 52 340-340

[7]

Terada K(1968)Prevention of Wilson’s disease in asymptomatic patients: prophylaxis of Wilson’s disease N Engl J Med 278 352-355

[8]

Schilsky ML(1987)Worsening of neurologic syndrome in patients with Wilson’s disease with metal penicillamine therapy Arch Neurol 44 490-493

[9]

Miura N(1999)Potential hepatotoxicity of penicillamine treatment in three patients with Wilson’s disease J Pediatr Gastroenterol Nutr 29 628-628

[10]

Sugiyama T(1987)The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson’s disease N Engl J Med 317 209-213

← 1 2 3 4 5 6 →